and undergo inflatable penile prosthesis (IPP) placement. These patients carry underlying risk factors associated with their disease, but are also predisposed to poor bladder emptying, urinary incontinence and need for prolonged catheterization after surgery. We compared patients with NGB undergoing IPP to a non-neurogenic control group. METHODS: From 2007-2018 patients with documented neurogenic bladder and known concomitant neurologic diagnosis (spinal cord injury, Parkinson's disease, multiple sclerosis, diabetes, stroke/ brain injury) underwent IPP placement. This group was compared to 162 non-neurogenic control patients undergoing IPP surgery during the same time period with respect to clinical and demographic characteristics as well as surgical outcomes. Chi-square test was used for categorical variables and Wilcoxon rank sum for continuous variables. Poisson regression was used to evaluate relative risk of complications between the two groups, adjusted for confounding factors.
INTRODUCTION AND OBJECTIVES: Many patients with neurogenic bladder (NGB) have concomitant erectile dysfunction (ED)
and undergo inflatable penile prosthesis (IPP) placement. These patients carry underlying risk factors associated with their disease, but are also predisposed to poor bladder emptying, urinary incontinence and need for prolonged catheterization after surgery. We compared patients with NGB undergoing IPP to a non-neurogenic control group. METHODS: From 2007 -2018 patients with documented neurogenic bladder and known concomitant neurologic diagnosis (spinal cord injury, Parkinson's disease, multiple sclerosis, diabetes, stroke/ brain injury) underwent IPP placement. This group was compared to 162 non-neurogenic control patients undergoing IPP surgery during the same time period with respect to clinical and demographic characteristics as well as surgical outcomes. Chi-square test was used for categorical variables and Wilcoxon rank sum for continuous variables. Poisson regression was used to evaluate relative risk of complications between the two groups, adjusted for confounding factors.
RESULTS: Patients with NGB were significantly younger, had more prior IPP surgeries, were more likely to require urine control management, and had more IPP related complications (infection, erosion, mechanical failure) ((52.5% vs 8%) p<0.0001). There was no significant difference in the year of surgery, BMI, ethnicity, individual or total number of comorbidities. After adjusting for confounding factors, including age and number of IPP's, relative risk of complication from IPP was significantly higher with NGB patients vs non neurogenic controls ((RR[2.5)(p<0.0001)) CONCLUSIONS: NGB is an independent risk factor for complications associated with IPP placement. Patients should be counseled accordingly and all efforts should be made to optimize bladder function prior to surgery. METHODS: IPP-naïve men over 65 years were prospectively recruited from our outpatient urology clinic. Demographic and selected medical history were recorded. Study participants were asked to squeeze a dynamometer between their thumb and index finger while seated with their arm resting at 90 degrees to measure their key pinch strength. The strongest of three attempts was recorded. Participants were then asked to operate three separate IPP devices (Coloplast Titan, Coloplast Titan Touch, and AMS 700) installed within identical penis models. The number of pumps required to achieve erection with each device was recorded. Patients were asked to rate the difficulty of pumping each device from 1 to 5. Participants were then asked to rank, from best to worst, which device they preferred based on ease of inflation. Multivariate linear regression at the 95% confidence interval was utilized to identify factors associated with difficulty of pumping rated 1 to 5. The order in which the models were presented to participants was randomized to eliminate patient fatigue and bias. RESULTS: A total of 100 men have completed the study. Median age and mean key pinch strength were 70.0 (range 65 to 87) years and 19.5 (SD AE4.2) lbs (comparable to published data among men older than 65 years). The Coloplast Titan pump was ranked the most favored pump based on ease of inflation (58%). AMS 700 was favored by 29% and Coloplast Titan Touch model was favored by 13% of the men. Interestingly, the median age (70.0, 69.0, and 73.0) and mean key pinch strength (19.6, 19.7, and 19 .1 pounds) were similar among men that favored Coloplast Titan as compared to the AMS and Coloplast Titan Touch pump. The median number of pumps required to achieve erection (5.0, 5.0, 6.0) was also similar across the Coloplast Titan, AMS 700, and Coloplast Titan Touch models. Multivariate linear regression of the 1 to 5 difficulty of inflation rating scale showed decreasing grip strength to be associated with increased difficulty of inflation for the Coloplast Titan Touch model (p [ 0.045) . No other factors were significantly associated increased difficulty of inflation. Strengths of our study include strict inclusion criteria, homogeneity of our study population, and randomization of models presented to participants. Limitations include small sample size.
Source of
CONCLUSIONS: Overall the Coloplast Titan pump was preferred compared to the AMS 700 or the Coloplast Titan Touch pumps based on ease of inflation using a penile implant model. Men with below average key pinch strength can benefit with ease of inflation from being offered a model other than Coloplast Titan Touch. Whether these findings translate to when men receive implants remains to be determined. Nevertheless, key pinch strength should be considered in men prior implantation of IPP. RESULTS: 20,726 males underwent radical prostatectomy and 2,352 males underwent radical cystectomy during the study period. 4.0% and 2.1% of patients had subsequent prosthesis placement, respectively. Prosthesis was placed at an average of 754 days following prostatectomy and 517 days following cystectomy. Patient characteristics for each subgroup can be seen in Table 1 . Adjusted risk factors for prosthesis following prostatectomy included Black race (OR 1.43, p<0.005) Hispanic race (OR 3.27, p<0.005), Medicare insurance (OR 1.71, p<0.005), and open surgery (OR 1.37, p<0.005). Adjusted risk factors for prosthesis following cystectomy included Hispanic race (OR 4.59, p<0.005).
CONCLUSIONS: Despite known impotence rates following radical prostatectomy and radical cystectomy approaching 40%, penile prosthesis is only utilized seldomly in these patients. Further investigation is warranted to determine barriers to prosthetic adoption. Despite popularity of the Mulcahy IPP washout protocol, Betadine has known tissue toxicity. We evaluated IPP infection rate based on the type of intraoperative irrigation utilized, Betadine (10%) versus Vancomycin / Gentamicin, and other factors which may affect infection rate.
METHODS: We reviewed a consecutive series from a detailed, prospective database of men undergoing primary, revision, and salvage penile prostheses at our institution. The primary outcome was rate of IPP infection prior to and following change of intra-operative irrigation. No other changes to operative or perioperative techniques occurred following the change in irrigation solution. Univariate and regression analyses were used to evaluate differences in infection rate with use of Betadine versus Vancomycin/Gentamicin irrigation. Multiple potential confounders were reviewed including patient demographics, comorbidities, type of surgery (primary, revision, salvage), prior penile surgery, and adjunctive techniques.
RESULTS: A total of 217 patients (mean age 65 years) underwent IPP placement at our institution from January 2014 to April 2018, of whom 21 (9.7%) experienced an infection (primary[10 (7.1%), revision[11 (17.19%) , salvage[0 (0%)). Overall, 152 (70%) received irrigation with Betadine compared to 65 (30%) with Vancomycin/ Gentamicin. Univariate analysis demonstrated significantly increased infection rates with Betadine irrigation (OR 4.64, p[0.006) and with revision surgery (OR 2.68, p [ 0.02) . Significance of increased infection rate with Betadine was maintained (OR 9.3; p[0.025) after controlling for age, BMI, Charleson Comorbidity Index, smoking, diabetes, primary vs revision/salvage, prior penile surgery, use of ectopic reservoir, and adjunctive glanulopexy.
CONCLUSIONS: Changing from intra-operative Betadine to Vancomycin / Gentamicin solution dramatically reduced infection rates among men undergoing IPP placement in both primary and revision cases. We hypothesize that differences in infection rate may relate to
